{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:03:53Z","timestamp":1792796633370,"version":"4.5.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["1RF1NS130834"],"award-info":[{"award-number":["1RF1NS130834"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-026-02084-7","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T06:16:00Z","timestamp":1779171360000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["TNF inhibition differentially impacts regional Abeta immunotherapy efficacy in the humanized hAbSAA mouse model"],"prefix":"10.1186","volume":"18","author":[{"given":"Katelynn E.","family":"Krick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L.","family":"Chalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua T.","family":"Lykins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Pei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chloe A.","family":"Ferguson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Salman","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica M.","family":"Weekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Wilcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"issue":"5","key":"2084_CR1","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.1002\/alz.13809","volume":"20","author":"Alzheimer's disease facts and figures","year":"2024","unstructured":"Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2024;20(5):3708\u2013821.","journal-title":"Alzheimers Dement"},{"issue":"6740","key":"2084_CR2","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 1999;400(6740):173\u20137.","journal-title":"Nature"},{"issue":"2","key":"2084_CR3","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr.","year":"2013","unstructured":"Jack CR Jr., Knopman DS, Jagust WJ, Petersen RC, Weiner MW, Aisen PS, et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013;12(2):207\u201316.","journal-title":"Lancet Neurol"},{"issue":"1","key":"2084_CR4","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1056\/NEJMoa2212948","volume":"388","author":"CH van Dyck","year":"2023","unstructured":"van Dyck CH, Swanson CJ, Aisen P, Bateman RJ, Chen C, Gee M, et al. Lecanemab in early Alzheimer\u2019s disease. N Engl J Med. 2023;388(1):9\u201321.","journal-title":"N Engl J Med"},{"issue":"18","key":"2084_CR5","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","volume":"384","author":"MA Mintun","year":"2021","unstructured":"Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, et al. Donanemab in early Alzheimer\u2019s disease. N Engl J Med. 2021;384(18):1691\u2013704.","journal-title":"N Engl J Med"},{"issue":"1","key":"2084_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1742-2094-1-24","volume":"1","author":"DM Wilcock","year":"2004","unstructured":"Wilcock DM, Rojiani A, Rosenthal A, Subbarao S, Freeman MJ, Gordon MN, et al. Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation. 2004;1(1):24.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"2084_CR7","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","volume":"7","author":"RA Sperling","year":"2011","unstructured":"Sperling RA, Jack CR Jr., Black SE, Frosch MP, Greenberg SM, Hyman BT, et al. Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup. Alzheimers Dement. 2011;7(4):367\u201385.","journal-title":"Alzheimers Dement"},{"issue":"11","key":"2084_CR8","doi-asserted-by":"publisher","first-page":"4414","DOI":"10.1093\/brain\/awad188","volume":"146","author":"H Hampel","year":"2023","unstructured":"Hampel H, Elhage A, Cho M, Apostolova LG, Nicoll JAR, Atri A. Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics. Brain. 2023;146(11):4414\u201324.","journal-title":"Brain"},{"issue":"7_supplement_1","key":"2084_CR9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000205071","volume":"102","author":"S Greenberg","year":"2024","unstructured":"Greenberg S, Battioui C, Lu M, Biffi A, Ardayfio P, Zimmer J, et al. ARIA insights from the Donanemab trials (P1-9.001). Neurology. 2024;102(7_supplement_1):3339.","journal-title":"Neurology"},{"issue":"5","key":"2084_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1056\/NEJMc2215148","volume":"388","author":"NJ Reish","year":"2023","unstructured":"Reish NJ, Jamshidi P, Stamm B, Flanagan ME, Sugg E, Tang M, et al. Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke. N Engl J Med. 2023;388(5):478\u20139.","journal-title":"N Engl J Med"},{"issue":"1","key":"2084_CR11","doi-asserted-by":"publisher","first-page":"8220","DOI":"10.1038\/s41467-023-43933-5","volume":"14","author":"E Solopova","year":"2023","unstructured":"Solopova E, Romero-Fernandez W, Harmsen H, Ventura-Antunes L, Wang E, Shostak A, et al. Fatal iatrogenic cerebral beta-amyloid-related arteritis in a woman treated with lecanemab for Alzheimer\u2019s disease. Nat Commun. 2023;14(1):8220.","journal-title":"Nat Commun"},{"issue":"4","key":"2084_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41582-024-01053-8","volume":"21","author":"SM Greenberg","year":"2025","unstructured":"Greenberg SM, Bax F, van Veluw SJ. Amyloid-related imaging abnormalities: Manifestations, metrics and mechanisms. Nat Rev Neurol. 2025;21(4):193\u2013203.","journal-title":"Nat Rev Neurol"},{"issue":"3","key":"2084_CR13","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/s00401-010-0719-5","volume":"120","author":"D Boche","year":"2010","unstructured":"Boche D, Denham N, Holmes C, Nicoll JA. Neuropathology after active Abeta42 immunotherapy: Implications for Alzheimer\u2019s disease pathogenesis. Acta Neuropathol. 2010;120(3):369\u201384.","journal-title":"Acta Neuropathol"},{"issue":"5","key":"2084_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcac245","volume":"4","author":"MG Kozberg","year":"2022","unstructured":"Kozberg MG, Yi I, Freeze WM, Auger CA, Scherlek AA, Greenberg SM, et al. Blood-brain barrier leakage and perivascular inflammation in cerebral amyloid angiopathy. Brain Commun. 2022;4(5):fcac245.","journal-title":"Brain Commun"},{"issue":"2","key":"2084_CR15","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3233\/JAD-221305","volume":"93","author":"RJ Castellani","year":"2023","unstructured":"Castellani RJ, Shanes ED, McCord M, Reish NJ, Flanagan ME, Mesulam MM, et al. Neuropathology of Anti-Amyloid-beta Immunotherapy: A Case Report. J Alzheimers Dis. 2023;93(2):803\u201313.","journal-title":"J Alzheimers Dis"},{"key":"2084_CR16","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2025.107013","volume":"213","author":"KE Krick","year":"2025","unstructured":"Krick KE, Weekman EM, Johnson SN, Sudduth TL, Rogers CB, Nicolayson EJ, et al. Age-related cerebral amyloid angiopathy accumulation in the APPSw mouse model is associated with perivascular inflammation and brain-wide vascular and inflammatory gene and protein changes. Neurobiol Dis. 2025;213:107013.","journal-title":"Neurobiol Dis"},{"key":"2084_CR17","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neuroscience.2016.11.024","volume":"341","author":"TL Sudduth","year":"2017","unstructured":"Sudduth TL, Weekman EM, Price BR, Gooch JL, Woolums A, Norris CM, et al. Time-course of glial changes in the hyperhomocysteinemia model of vascular cognitive impairment and dementia (VCID). Neuroscience. 2017;341:42\u201351.","journal-title":"Neuroscience"},{"issue":"1","key":"2084_CR18","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s12974-019-1685-z","volume":"16","author":"EM Weekman","year":"2019","unstructured":"Weekman EM, Sudduth TL, Price BR, Woolums AE, Hawthorne D, Seaks CE, et al. Time course of neuropathological events in hyperhomocysteinemic amyloid depositing mice reveals early neuroinflammatory changes that precede amyloid changes and cerebrovascular events. J Neuroinflammation. 2019;16(1):284.","journal-title":"J Neuroinflammation"},{"issue":"5","key":"2084_CR19","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1042\/AN20110018","volume":"3","author":"DM Wilcock","year":"2011","unstructured":"Wilcock DM, Zhao Q, Morgan D, Gordon MN, Everhart A, Wilson JG, et al. Diverse inflammatory responses in transgenic mouse models of Alzheimer\u2019s disease and the effect of immunotherapy on these responses. ASN Neuro. 2011;3(5):249\u201358.","journal-title":"ASN Neuro"},{"issue":"1","key":"2084_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s40478-021-01264-w","volume":"9","author":"A Jayaraman","year":"2021","unstructured":"Jayaraman A, Htike TT, James R, Picon C, Reynolds R. TNF-mediated neuroinflammation is linked to neuronal necroptosis in Alzheimer\u2019s disease hippocampus. Acta Neuropathol Commun. 2021;9(1):159.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2084_CR21","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12987-019-0123-z","volume":"16","author":"C Greene","year":"2019","unstructured":"Greene C, Hanley N, Campbell M. Claudin-5: Gatekeeper of neurological function. Fluids Barriers CNS. 2019;16(1):3.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"2084_CR22","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1161\/01.RES.75.1.181","volume":"75","author":"ZS Galis","year":"1994","unstructured":"Galis ZS, Muszynski M, Sukhova GK, Simon-Morrissey E, Unemori EN, Lark MW, et al. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ Res. 1994;75(1):181\u20139.","journal-title":"Circ Res"},{"issue":"2","key":"2084_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.pharmthera.2007.10.001","volume":"117","author":"D Tracey","year":"2008","unstructured":"Tracey D, Klareskog L, Sasso EH, Salfeld JG, Tak PP. Tumor necrosis factor antagonist mechanisms of action: a comprehensive review. Pharmacol Ther. 2008;117(2):244\u201379.","journal-title":"Pharmacol Ther"},{"issue":"3","key":"2084_CR24","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3233\/JPD-140410","volume":"4","author":"CJ Barnum","year":"2014","unstructured":"Barnum CJ, Chen X, Chung J, Chang J, Williams M, Grigoryan N, et al. Peripheral administration of the selective inhibitor of soluble tumor necrosis factor (TNF) XPro(R)1595 attenuates nigral cell loss and glial activation in 6-OHDA hemiparkinsonian rats. J Parkinsons Dis. 2014;4(3):349\u201360.","journal-title":"J Parkinsons Dis"},{"key":"2084_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.nbd.2017.02.010","volume":"102","author":"KP MacPherson","year":"2017","unstructured":"MacPherson KP, Sompol P, Kannarkat GT, Chang J, Sniffen L, Wildner ME, et al. Peripheral administration of the soluble TNF inhibitor XPro1595 modifies brain immune cell profiles, decreases beta-amyloid plaque load, and rescues impaired long-term potentiation in 5xFAD mice. Neurobiol Dis. 2017;102:81\u201395.","journal-title":"Neurobiol Dis"},{"issue":"Pt 9","key":"2084_CR26","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1093\/brain\/awr199","volume":"134","author":"R Brambilla","year":"2011","unstructured":"Brambilla R, Ashbaugh JJ, Magliozzi R, Dellarole A, Karmally S, Szymkowski DE, et al. Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelination. Brain. 2011;134(Pt 9):2736\u201354.","journal-title":"Brain"},{"key":"2084_CR27","doi-asserted-by":"publisher","unstructured":"Larson K, Damon M, Randhi R, Nixon-Lee N, Dixon KJ. Selective inhibition of soluble TNF using XPro1595 improves hippocampal pathology to promote improved neurological recovery following traumatic brain injury in mice. CNS Neurol Disord Drug Targets. 2023;22(9):1378\u201390. https:\/\/doi.org\/10.2174\/1871527321666220610104908.","DOI":"10.2174\/1871527321666220610104908"},{"issue":"1","key":"2084_CR28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s40478-020-00957-y","volume":"8","author":"BH Clausen","year":"2020","unstructured":"Clausen BH, Wirenfeldt M, Hogedal SS, Frich LH, Nielsen HH, Schroder HD, et al. Characterization of the TNF and IL-1 systems in human brain and blood after ischemic stroke. Acta Neuropathol Commun. 2020;8(1):81.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"2084_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s13024-023-00649-w","volume":"18","author":"X Taylor","year":"2023","unstructured":"Taylor X, Clark IM, Fitzgerald GJ, Oluoch H, Hole JT, DeMattos RB, et al. Amyloid-beta (Abeta) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer\u2019s disease mice. Mol Neurodegener. 2023;18(1):59.","journal-title":"Mol Neurodegener"},{"issue":"1","key":"2084_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13024-024-00758-0","volume":"19","author":"X Taylor","year":"2024","unstructured":"Taylor X, Noristani HN, Fitzgerald GJ, Oluoch H, Babb N, McGathey T, et al. Amyloid-beta (Abeta) immunotherapy induced microhemorrhages are linked to vascular inflammation and cerebrovascular damage in a mouse model of Alzheimer\u2019s disease. Mol Neurodegener. 2024;19(1):77.","journal-title":"Mol Neurodegener"},{"key":"2084_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuropharm.2018.09.001","volume":"143","author":"S Gustafsson","year":"2018","unstructured":"Gustafsson S, Gustavsson T, Roshanbin S, Hultqvist G, Hammarlund-Udenaes M, Sehlin D, et al. Blood-brain barrier integrity in a mouse model of Alzheimer\u2019s disease with or without acute 3D6 immunotherapy. Neuropharmacology. 2018;143:1\u20139.","journal-title":"Neuropharmacology"},{"issue":"2","key":"2084_CR32","doi-asserted-by":"publisher","first-page":"723","DOI":"10.3233\/JAD-160023","volume":"54","author":"I Blockx","year":"2016","unstructured":"Blockx I, Einstein S, Guns PJ, Van Audekerke J, Guglielmetti C, Zago W, et al. Monitoring Blood-Brain Barrier Integrity Following Amyloid-beta Immunotherapy Using Gadolinium-Enhanced MRI in a PDAPP Mouse Model. J Alzheimers Dis. 2016;54(2):723\u201335.","journal-title":"J Alzheimers Dis"},{"key":"2084_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2023.895017","volume":"17","author":"KP MacPherson","year":"2023","unstructured":"MacPherson KP, Eidson LN, Houser MC, Weiss BE, Gollihue JL, Herrick MK, et al. Soluble TNF mediates amyloid-independent, diet-induced alterations to immune and neuronal functions in an Alzheimer\u2019s disease mouse model. Front Cell Neurosci. 2023;17:895017.","journal-title":"Front Cell Neurosci"},{"key":"2084_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuroimage.2021.118175","volume":"237","author":"K Eckstein","year":"2021","unstructured":"Eckstein K, Bachrata B, Hangel G, Widhalm G, Enzinger C, Barth M, et al. Improved susceptibility weighted imaging at ultra-high field using bipolar multi-echo acquisition and optimized image processing: CLEAR-SWI. Neuroimage. 2021;237:118175.","journal-title":"Neuroimage"},{"issue":"7","key":"2084_CR35","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1523\/JNEUROSCI.5066-07.2008","volume":"28","author":"DM Wilcock","year":"2008","unstructured":"Wilcock DM, Lewis MR, Van Nostrand WE, Davis J, Previti ML, Gharkholonarehe N, et al. Progression of amyloid pathology to Alzheimer\u2019s disease pathology in an amyloid precursor protein transgenic mouse model by removal of nitric oxide synthase 2. The Journal of neuroscience\u202f: the official journal of the Society for Neuroscience. 2008;28(7):1537\u201345.","journal-title":"The Journal of neuroscience : the official journal of the Society for Neuroscience"},{"issue":"3","key":"2084_CR36","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1038\/nprot.2006.277","volume":"1","author":"DM Wilcock","year":"2006","unstructured":"Wilcock DM, Gordon MN, Morgan D. Quantification of cerebral amyloid angiopathy and parenchymal amyloid plaques with Congo red histochemical stain. Nat Protoc. 2006;1(3):1591\u20135.","journal-title":"Nat Protoc"},{"issue":"2","key":"2084_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0031993","volume":"7","author":"TL Sudduth","year":"2012","unstructured":"Sudduth TL, Wilson JG, Everhart A, Colton CA, Wilcock DM. Lithium treatment of APPSwDI\/NOS2-\/- mice leads to reduced hyperphosphorylated tau, increased amyloid deposition and altered inflammatory phenotype. PLoS ONE. 2012;7(2):e31993.","journal-title":"PLoS ONE"},{"issue":"1","key":"2084_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03332-7","volume":"22","author":"EM Weekman","year":"2025","unstructured":"Weekman EM, Rogers CB, Sudduth TL, Wilcock DM. Hyperhomocysteinemia-induced VCID results in visual deficits, reduced neuroinflammation and vascular alterations in the retina. J Neuroinflammation. 2025;22(1):23.","journal-title":"J Neuroinflammation"},{"issue":"4","key":"2084_CR39","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1002\/glia.23941","volume":"69","author":"M BelmaatiCherkaoui","year":"2021","unstructured":"BelmaatiCherkaoui M, Vacca O, Izabelle C, Boulay AC, Boulogne C, Gillet C, et al. Dp71 contribution to the molecular scaffold anchoring aquaporine-4 channels in brain macroglial cells. Glia. 2021;69(4):954\u201370.","journal-title":"Glia"},{"issue":"5","key":"2084_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/s41593-020-00793-2","volume":"24","author":"DA Hartmann","year":"2021","unstructured":"Hartmann DA, Berthiaume AA, Grant RI, Harrill SA, Koski T, Tieu T, et al. Brain capillary pericytes exert a substantial but slow influence on blood flow. Nat Neurosci. 2021;24(5):633\u201345.","journal-title":"Nat Neurosci"},{"issue":"11","key":"2084_CR41","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1007\/s00109-017-1573-x","volume":"95","author":"G Faraco","year":"2017","unstructured":"Faraco G, Park L, Anrather J, Iadecola C. Brain perivascular macrophages: characterization and functional roles in health and disease. J Mol Med (Berl). 2017;95(11):1143\u201352.","journal-title":"J Mol Med (Berl)"},{"key":"2084_CR42","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.neuroscience.2015.06.038","volume":"302","author":"L Probert","year":"2015","unstructured":"Probert L. TNF and its receptors in the CNS: the essential, the desirable and the deleterious effects. Neuroscience. 2015;302:2\u201322.","journal-title":"Neuroscience"},{"issue":"6","key":"2084_CR43","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1002\/alz.12465","volume":"18","author":"C Zheng","year":"2022","unstructured":"Zheng C, Fillmore NR, Ramos-Cejudo J, Brophy M, Osorio R, Gurney ME, et al. Potential long-term effect of tumor necrosis factor inhibitors on dementia risk: A propensity score matched retrospective cohort study in US veterans. Alzheimers Dement. 2022;18(6):1248\u201359.","journal-title":"Alzheimers Dement"},{"key":"2084_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106325","volume":"182","author":"A Watad","year":"2022","unstructured":"Watad A, McGonagle D, Anis S, Carmeli R, Cohen AD, Tsur AM, et al. TNF inhibitors have a protective role in the risk of dementia in patients with ankylosing spondylitis: results from a nationwide study. Pharmacol Res. 2022;182:106325.","journal-title":"Pharmacol Res"},{"issue":"1-2","key":"2084_CR45","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jbiotec.2010.01.011","volume":"146","author":"RJ Boado","year":"2010","unstructured":"Boado RJ, Hui EK, Lu JZ, Zhou QH, Pardridge WM. Selective targeting of a TNFR decoy receptor pharmaceutical to the primate brain as a receptor-specific IgG fusion protein. J Biotechnol. 2010;146(1\u20132):84\u201391.","journal-title":"J Biotechnol"},{"key":"2084_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00106","volume":"9","author":"S Dadsetan","year":"2016","unstructured":"Dadsetan S, Balzano T, Forteza J, Cabrera-Pastor A, Taoro-Gonzalez L, Hernandez-Rabaza V, et al. Reducing peripheral inflammation with Infliximab reduces neuroinflammation and improves cognition in rats with hepatic encephalopathy. Front Mol Neurosci. 2016;9:106.","journal-title":"Front Mol Neurosci"},{"issue":"9","key":"2084_CR47","doi-asserted-by":"publisher","first-page":"4620","DOI":"10.4049\/jimmunol.168.9.4620","volume":"168","author":"DR Roach","year":"2002","unstructured":"Roach DR, Bean AG, Demangel C, France MP, Briscoe H, Britton WJ. TNF regulates chemokine induction essential for cell recruitment, granuloma formation, and clearance of mycobacterial infection. J Immunol. 2002;168(9):4620\u20137.","journal-title":"J Immunol"},{"key":"2084_CR48","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25020817","author":"AF Batista","year":"2024","unstructured":"Batista AF, Khan KA, Papavergi MT, Lemere CA. The importance of complement-mediated immune signaling in Alzheimer\u2019s disease pathogenesis. Int J Mol Sci. 2024. https:\/\/doi.org\/10.3390\/ijms25020817.","journal-title":"Int J Mol Sci"},{"issue":"11","key":"2084_CR49","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/mp.2009.10","volume":"14","author":"J Chapuis","year":"2009","unstructured":"Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, Hubans C, et al. Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer\u2019s disease. Mol Psychiatry. 2009;14(11):1004\u201316.","journal-title":"Mol Psychiatry"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-026-02084-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02084-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-026-02084-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T03:43:46Z","timestamp":1783914226000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13195-026-02084-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2084"],"URL":"https:\/\/doi.org\/10.1186\/s13195-026-02084-7","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Indiana University Institutional Animal Care and Use Committee and conformed to the National Institutes of Health Guide of the Care and Use of Animals and Research and ARRIVE guidelines (Animal Research: Reporting of In Vivo Experiments).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare the following financial interests\/personal relationships which may be considered potential competing interests: DMW reports relationships with the following: Longeveron LLC (consulting or advisory), Vigil Neuroscience Inc. (consulting or advisory), SynapsDx (consulting or advisory), Alzheimer\u2019s & Dementia (board membership).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"161"}}